Details for New Drug Application (NDA): 078052
✉ Email this page to a colleague
NDA 078052 describes FOSPHENYTOIN SODIUM, which is a drug marketed by Am Regent, Amneal, Apotex Inc, Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Norvium Bioscience, Sun Pharm, and Wockhardt, and is included in fourteen NDAs. It is available from six suppliers. Additional details are available on the FOSPHENYTOIN SODIUM profile page.
The generic ingredient in FOSPHENYTOIN SODIUM is fosphenytoin sodium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fosphenytoin sodium profile page.
The generic ingredient in FOSPHENYTOIN SODIUM is fosphenytoin sodium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fosphenytoin sodium profile page.
Summary for 078052
| Tradename: | FOSPHENYTOIN SODIUM |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | fosphenytoin sodium |
| Patents: | 0 |
Pharmacology for NDA: 078052
Suppliers and Packaging for NDA: 078052
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FOSPHENYTOIN SODIUM | fosphenytoin sodium | INJECTABLE;INJECTION | 078052 | ANDA | Fresenius Kabi USA, LLC | 63323-403 | 63323-403-02 | 25 VIAL in 1 TRAY (63323-403-02) / 2 mL in 1 VIAL (63323-403-01) |
| FOSPHENYTOIN SODIUM | fosphenytoin sodium | INJECTABLE;INJECTION | 078052 | ANDA | Fresenius Kabi USA, LLC | 63323-403 | 63323-403-10 | 10 VIAL in 1 TRAY (63323-403-10) / 10 mL in 1 VIAL (63323-403-04) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG PHENYTOIN NA/ML | ||||
| Approval Date: | Aug 6, 2007 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
